These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 11931626)
61. Structural Insights for Drugs Developed for Phospholipase D Enzymes. Stieglitz KA Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238 [TBL] [Abstract][Full Text] [Related]
62. Discovery of novel class 1 phosphatidylinositide 3-kinases (PI3K) fragment inhibitors through structure-based virtual screening. Giordanetto F; Kull B; Dellsén A Bioorg Med Chem Lett; 2011 Jan; 21(2):829-35. PubMed ID: 21169017 [TBL] [Abstract][Full Text] [Related]
63. vSDC: a method to improve early recognition in virtual screening when limited experimental resources are available. Chaput L; Martinez-Sanz J; Quiniou E; Rigolet P; Saettel N; Mouawad L J Cheminform; 2016; 8():1. PubMed ID: 26807156 [TBL] [Abstract][Full Text] [Related]
64. An Aggregation Advisor for Ligand Discovery. Irwin JJ; Duan D; Torosyan H; Doak AK; Ziebart KT; Sterling T; Tumanian G; Shoichet BK J Med Chem; 2015 Sep; 58(17):7076-87. PubMed ID: 26295373 [TBL] [Abstract][Full Text] [Related]
65. Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes. Bachovchin DA; Brown SJ; Rosen H; Cravatt BF Nat Biotechnol; 2009 Apr; 27(4):387-94. PubMed ID: 19329999 [TBL] [Abstract][Full Text] [Related]
66. How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics Study. Ghattas MA; Al Rawashdeh S; Atatreh N; Bryce RA J Chem Inf Model; 2020 Aug; 60(8):3901-3909. PubMed ID: 32628846 [TBL] [Abstract][Full Text] [Related]
67. Aggregating behavior of phenolic compounds--a source of false bioassay results? Pohjala L; Tammela P Molecules; 2012 Sep; 17(9):10774-90. PubMed ID: 22960870 [TBL] [Abstract][Full Text] [Related]
68. DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors. Tomohara K; Adachi I; Horino Y; Kesamaru H; Abe H; Suyama K; Nose T ACS Med Chem Lett; 2019 Jun; 10(6):923-928. PubMed ID: 31223449 [TBL] [Abstract][Full Text] [Related]
69. Identification of non-substrate-like glycosyltransferase inhibitors from library screening: pitfalls & hits. Ema M; Xu Y; Gehrke S; Wagner GK Medchemcomm; 2018 Jan; 9(1):131-137. PubMed ID: 30108907 [TBL] [Abstract][Full Text] [Related]
71. A structure-guided computational screening approach for predicting plant enzyme-metabolite interactions. Holland CK; Tadfie H Methods Enzymol; 2022; 676():71-101. PubMed ID: 36280362 [TBL] [Abstract][Full Text] [Related]
72. Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration. Kwarcinski FE; Steffey ME; Fox CC; Soellner MB ACS Med Chem Lett; 2015 Aug; 6(8):898-901. PubMed ID: 26286460 [TBL] [Abstract][Full Text] [Related]
73. From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules. Kaoud TS; Yan C; Mitra S; Tseng CC; Jose J; Taliaferro JM; Tuohetahuntila M; Devkota A; Sammons R; Park J; Park H; Shi Y; Hong J; Ren P; Dalby KN ACS Med Chem Lett; 2012 Aug; 3(9):721-725. PubMed ID: 23002419 [TBL] [Abstract][Full Text] [Related]
74. MO-MEMES: A method for accelerating virtual screening using multi-objective Bayesian optimization. Mehta S; Goel M; Priyakumar UD Front Med (Lausanne); 2022; 9():916481. PubMed ID: 36213671 [TBL] [Abstract][Full Text] [Related]